Sandhya Sanduja, Ph.D.
Affiliations: | 2011 | Biological Sciences | University of South Carolina, Columbia, SC |
Area:
Molecular Biology, Cell Biology, OncologyGoogle:
"Sandhya Sanduja"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Dan A. Dixon | grad student | 2011 | University of South Carolina | |
| (The role of the RNA-binding protein tristetraprolin in cervical and colorectal cancers.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Vishwakarma V, Sanduja S, Zhuang S, et al. (2018) 832 - The RNA-Binding Protein Tristetraprolin Controls Intestinal Cell Differentiation and Bacterial Symbiosis Through the Notch Signaling Pathway Gastroenterology. 154: S-173 |
| Sokol ES, Feng YX, Jin DX, et al. (2017) SMARCE1 is required for the invasive progression of in situ cancers. Proceedings of the National Academy of Sciences of the United States of America |
| Sanduja S, Feng Y, Mathis RA, et al. (2016) AMPK promotes tolerance to Ras pathway inhibition by activating autophagy. Oncogene |
| Sobolewski C, Sanduja S, Blanco FF, et al. (2015) Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells. Biomolecules. 5: 2035-55 |
| Sokol ES, Sanduja S, Jin DX, et al. (2015) Perturbation-expression analysis identifies RUNX1 as a regulator of human mammary stem cell differentiation. Plos Computational Biology. 11: e1004161 |
| Feng Y, Sokol ES, Vecchio CAD, et al. (2015) Abstract P2-07-01: EMT activates PERK-eIF2α signaling and sensitizes cells to perturbations in endoplasmic reticulum function Cancer Research. 75 |
| Vecchio CAD, Feng Y, Sokol ES, et al. (2015) Abstract LB-244: Amino acid deprivation selectively targets multidrug-resistant breast cancer cells Cancer Research. 75 |
| Zhuang S, Hu L, Sanduja S, et al. (2015) Abstract 2130: The RNA-binding protein tristetraprolin controls intestinal cell differentiation and tumorigenesis through the Notch signaling pathway Cancer Research. 75: 2130-2130 |
| Zhuang S, Hu L, Sanduja S, et al. (2015) 174 The RNA-Binding Protein Tristetraprolin Controls Intestinal Cell Differentiation and Tumorigenesis Through the Notch Pathway Gastroenterology. 148: S-47 |
| Del Vecchio CA, Feng Y, Sokol ES, et al. (2014) De-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signaling. Plos Biology. 12: e1001945 |